Filed: 5/15/2024ACC: 0001104659-24-061948
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $2.10B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$2.10B
Total AUM (reported)
131.05M
Total Shares
Allocation by class
COM$1.89B89.7%
COM NEW$152.64M7.3%
COM SHS$25.83M1.2%
SPONSORED ADS$19.24M0.9%
SHS$18.39M0.9%
Portfolio Concentration
Top 3$820.70M39.0%
4–10$517.22M24.6%
11–25$598.57M28.5%
Rest$165.70M7.9%
Top 3 weight
39.0%
Top 10 weight
63.6%
Voting Authority Distribution
Total shares with voting rights: 131.05M
Sole
Full voting authority
131.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings38
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$564.38M
26.85%
Sole
8.49M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares4.40M
TypeSH
Market value$140.18M
6.67%
Sole
4.40M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares12.76M
TypeSH
Market value$116.14M
5.52%
Sole
12.76M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$82.38M
3.92%
Sole
2.17M
Shared
0.00
None
0.00
MERUS N V
SOLEShares1.79M
TypeSH
Market value$80.61M
3.83%
Sole
1.79M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares3.40M
TypeSH
Market value$78.47M
3.73%
Sole
3.40M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares6.25M
TypeSH
Market value$74.12M
3.53%
Sole
6.25M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares4.03M
TypeSH
Market value$70.82M
3.37%
Sole
4.03M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$67.99M
3.23%
Sole
3.88M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares2.09M
TypeSH
Market value$62.83M
2.99%
Sole
2.09M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$61.72M
2.94%
Sole
2.17M
Shared
0.00
None
0.00
APPLIED THERAPEUTICS INC
SOLEShares9.07M
TypeSH
Market value$61.71M
2.94%
Sole
9.07M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares4.39M
TypeSH
Market value$60.42M
2.87%
Sole
4.39M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares3.61M
TypeSH
Market value$50.79M
2.42%
Sole
3.61M
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares11.33M
TypeSH
Market value$50.75M
2.41%
Sole
11.33M
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares2.57M
TypeSH
Market value$43.49M
2.07%
Sole
2.57M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares706.13K
TypeSH
Market value$43.09M
2.05%
Sole
706.13K
Shared
0.00
None
0.00
HILLEVAX INC
SOLEShares2.08M
TypeSH
Market value$34.51M
1.64%
Sole
2.08M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.13M
TypeSH
Market value$34.47M
1.64%
Sole
5.13M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares1.82M
TypeSH
Market value$33.16M
1.58%
Sole
1.82M
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares1.56M
TypeSH
Market value$26.68M
1.27%
Sole
1.56M
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares627.79K
TypeSH
Market value$25.92M
1.23%
Sole
627.79K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares9M
TypeSH
Market value$25.83M
1.23%
Sole
9M
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
SOLEShares5.56M
TypeSH
Market value$23.67M
1.13%
Sole
5.56M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares3.41M
TypeSH
Market value$22.37M
1.06%
Sole
3.41M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $564.38M 26.85% | 8.49M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 4.40M | SH | $140.18M 6.67% | 4.40M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 12.76M | SH | $116.14M 5.52% | 12.76M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.17M | SH | $82.38M 3.92% | 2.17M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 1.79M | SH | $80.61M 3.83% | 1.79M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 3.40M | SH | $78.47M 3.73% | 3.40M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 6.25M | SH | $74.12M 3.53% | 6.25M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 4.03M | SH | $70.82M 3.37% | 4.03M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $67.99M 3.23% | 3.88M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 2.09M | SH | $62.83M 2.99% | 2.09M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $61.72M 2.94% | 2.17M | 0.00 | 0.00 |
APPLIED THERAPEUTICS INCSOLE | COM | 9.07M | SH | $61.71M 2.94% | 9.07M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 4.39M | SH | $60.42M 2.87% | 4.39M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 3.61M | SH | $50.79M 2.42% | 3.61M | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 11.33M | SH | $50.75M 2.41% | 11.33M | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 2.57M | SH | $43.49M 2.07% | 2.57M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 706.13K | SH | $43.09M 2.05% | 706.13K | 0.00 | 0.00 |
HILLEVAX INCSOLE | COM | 2.08M | SH | $34.51M 1.64% | 2.08M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 5.13M | SH | $34.47M 1.64% | 5.13M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 1.82M | SH | $33.16M 1.58% | 1.82M | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 1.56M | SH | $26.68M 1.27% | 1.56M | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 627.79K | SH | $25.92M 1.23% | 627.79K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 9M | SH | $25.83M 1.23% | 9M | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCSOLE | COM | 5.56M | SH | $23.67M 1.13% | 5.56M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 3.41M | SH | $22.37M 1.06% | 3.41M | 0.00 | 0.00 |
Page 1 of 2